To this end, we observed that the expression of CDC20 was significantly increased in stage 3 and stage 4 of KIRP, and stage2 and stage 3 of TGCT, but not the earlier stages in the presented cancer types (Figure 1D, P<0.05). The gene discussed is CDC20; the disease is cancer.